NORD — Nordicus Partners Corp

—
OTC · Unknown · Unknown · CIK 1011060 ·
Last close
$4.01
Market Cap
$77.97M
52W High
$5.95
52W Low
$1.48
ADV30
3,457
Next earnings
—
Nordicus Partners Corporation, a biotech company specializing in developing breakthrough therapeutics for diseases with unmet medical needs in the United States. It develops medicines supporting oral health. The company was formerly known as EKIMAS Corporation and changed its name to Nordicus Partners Corporation in May 2023. Nordicus Partners Corporation was founded in 1993 and is based in Beverly Hills, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Mar 2026 0 — -1,205,462 -56,112 75,463,346 20,878 11,225,463
Dec 2025 0 — -1,122,172 -1,227,214 75,856,649 189,297 11,106,028
Sep 2025 0 — -1,211,478 -1,511,474 75,882,821 242,155 11,215,508
Jun 2025 0 — -831,886 -1,206,886 76,124,458 8,418 11,863,490

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-4,324,775
Investing CF
$-10,158
Financing CF
$4,335,448
CapEx
$-8,762
Dividends Paid
$0
Buybacks
$0
EPS Diluted TTM
$-0.22
As of
2026-10-05

Balance + Analyst (yfinance extras)

Retained Earnings
$-50,786,534
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-3,371,162
Pretax Income TTM
$-4,046,804
Interest Exp TTM
$844
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$0
EBITDA
$-4,048,815
Free Cash Flow
$-2,477,439
Enterprise Value
$77,951,456
Total Cash
$5,784
Total Debt
$82,000
Shares Out
19,443,896
Trailing EPS
$-0.28
Book Value
$3.21
ROE
-8.2%
ROA
-3.7%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Mar 2026 0 -4,370,998 -4,001,686 75,463,346 11,225,463 64,281,660 -4,324,775
Mar 2025 5,000 -2,919,365 -2,901,321 70,246,329 10,381,075 59,865,254 -1,284,615
Mar 2024 2,500 -307,588 -298,202 1,807,573 26,405 1,781,168 -258,928
Mar 2023 0 -8,479,889 -8,472,216 55,025 27,367 27,658 -368,347
Mar 2022 — — — — — — —

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-4,551,978
OpCashFlow TTM
—
Assets (Latest)
$75,856,649
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
RFM RiverNorth Flexible Municipal Income Fund, Inc. $78.33M $12.81 —
AGRZ Agroz Inc. $78.46M $3.62 —
GGROU Golden Growers Cooperative $77.45M $5.00 —
NRT NORTH EUROPEAN OIL ROYALTY TRUST $77.38M $8.42 —
FMN Federated Hermes Premier Municipal Income Fund $77.25M $9.88 —

News headlines (Yahoo Finance, 1h cache)

Nordicus Partners Corporation Appoints Elizabeth Addonizio to Its Board of Directors
2026-09-02 13:28 · Yahoo
Nordicus Partners Corporation Corporate Update
2026-06-15 17:36 · Yahoo
NoviThera has initiated the first efficacy animal studies
2025-11-13 16:00 · Yahoo
Orocidin’s QR-01 Shows Positive Results in Treating Periodontitis in the treatment of experimental periodontitis in Wistar rats.
2025-10-22 13:00 · Yahoo
Orocidin develops novel cGMP manufacturing process in collaboration with Syngene
2025-10-20 13:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.